» Authors » Nicole Rotmensz

Nicole Rotmensz

Explore the profile of Nicole Rotmensz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 3012
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaidar-Person O, Antunes M, Cardoso J, Ciani O, Cruz H, Di Micco R, et al.
PLoS One . 2023 Aug; 18(8):e0289365. PMID: 37535564
Background: Breast cancer therapy improved significantly, allowing for different surgical approaches for the same disease stage, therefore offering patients different aesthetic outcomes with similar locoregional control. The purpose of the...
2.
Di Micco R, Santurro L, Gasparri M, Zuber V, Cisternino G, Baleri S, et al.
Cancers (Basel) . 2021 Jul; 13(14). PMID: 34298781
Axillary surgery in breast cancer (BC) is no longer a therapeutic procedure but has become a purely staging procedure. The progressive improvement in imaging techniques has paved the way to...
3.
Hong S, Chan T, Lombardo Y, Corleone G, Rotmensz N, Bravaccini S, et al.
Nat Commun . 2019 Sep; 10(1):3840. PMID: 31477698
Resistant tumours are thought to arise from the action of Darwinian selection on genetically heterogenous cancer cell populations. However, simple clonal selection is inadequate to describe the late relapses often...
4.
De Lorenzi F, Di Bella J, Maisonneuve P, Rotmensz N, Corso G, Orecchia R, et al.
Eur J Surg Oncol . 2018 May; 44(7):957-962. PMID: 29759643
Background: Few data exist in literature regarding oncoplastic surgery (ONC) and ductal carcinoma in situ (DCIS). The role of ONC in the treatment of DCIS has not been elucidated yet:...
5.
Criscitiello C, Bagnardi V, Pruneri G, Vingiani A, Esposito A, Rotmensz N, et al.
Eur J Cancer . 2017 Nov; 87:164-171. PMID: 29154173
Background: The standard treatment for patients with small, node-negative, human epidermal growth factor receptor type 2 (HER2)-positive breast cancer (BC) is still controversial. Our aim was to assess the prognostic...
6.
Renzi C, Perinel G, Arnaboldi P, Gandini S, Vadilonga V, Rotmensz N, et al.
BMC Psychol . 2017 Nov; 5(1):37. PMID: 29122005
Background: Breast cancer diagnosis and treatment represent stressful events that demand emotional adjustment, thus recruiting coping strategies and defense mechanisms. As parental relations were shown to influence emotion regulation patterns...
7.
Corso G, Grana C, Gilardi L, Baio S, De Lorenzo D, Maisonneuve P, et al.
Ann Ital Chir . 2017 Sep; 88:201-205. PMID: 28874624
Aim: To assess the sentinel-node identification rate at lymphoscintigraphy and its technical feasibility after neo-adjuvant treatments. Material Of Study: Between 2000 and 2013, 444 consecutive patients affected by primary locally...
8.
Leonardi M, Maisonneuve P, Mastropasqua M, Cattani F, Fanetti G, Morra A, et al.
Int J Radiat Oncol Biol Phys . 2017 Aug; 99(1):173-181. PMID: 28816144
Purpose: To investigate the local outcome of patients after accelerated partial breast irradiation with intraoperative electrons (IORT) for invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC). Methods And...
9.
Petit J, Maisonneuve P, Rotmensz N, Bertolini F, Rietjens M
Plast Reconstr Surg . 2017 May; 139(6):1292-1296. PMID: 28538546
Background: Fat grafting has been widely indicated for postmastectomy and postlumpectomy breast reconstruction. The literature emphasizes the clinical efficacy of fat grafting, but experimental studies raise important questions about the...
10.
Havas K, Milchevskaya V, Radic K, Alladin A, Kafkia E, Garcia M, et al.
J Clin Invest . 2017 May; 127(6):2091-2105. PMID: 28504653
Tumor recurrence is the leading cause of breast cancer-related death. Recurrences are largely driven by cancer cells that survive therapeutic intervention. This poorly understood population is referred to as minimal...